DXCM
DexCom, Inc. · Healthcare · Medical - Devices
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 166 | +2 | 299.42M | $20.12B | +7 | −7 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | — |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | — | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | — | — |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | — |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | — | −2 |
| Q2 2024 | 21 | — | 52.99M | $6.01B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 15.33M | — | $1.74B | 1.4% | n/c | 1 | SEC ↗ ×4 |
| 2 | Geode Capital Management ✦ (pasif) | 9.72M | — | $1.10B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 8.31M | — | $942.19M | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (pasif) | 5.39M | — | $611.04M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.33M | — | $604.48M | 0.1% | n/c | 1 | SEC ↗ ×12 |
| 6 | T. Rowe Price ✦ | 3.45M | — | $391.15M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Tiger Global Management ✦ | 1.15M | — | $130.71M | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 773.87K | — | $87.74M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 752.32K | — | $85.30M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 10 | Citadel Advisors ✦ | 727.88K | — | $82.53M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 11 | Renaissance Technologies ✦ | 462.57K | — | $52.45M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 389.00K | — | $44.10M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 351.31K | — | $39.83M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 14 | Bridgewater Associates ✦ | 347.32K | — | $39.38M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Soros Fund Management ✦ | 166.80K | — | $18.91M | 0.6% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 85.02K | — | $9.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Millennium Management ✦ | 64.49K | — | $7.31M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 54.97K | — | $6.23M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 52.00K | — | $5.90M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 47.88K | — | $5.43M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 35.74K | — | $4.05M | 0.0% | n/c | 1 | SEC ↗ ×2 |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 15.50K saham, $973 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.56K lbr · $220,975
Director · 6.54K lbr · $549,538
Officer · 1.70K lbr · $142,868
Director · 1.55K lbr · $130,231
Officer · 3.64K lbr · $302,936
Officer · 2.56K lbr · $226,669
Officer, Director · 19.31K lbr · $1.73M
Officer, Director · 97 lbr · $8,867
Officer, Director · 7.35K lbr · $667,332
Officer · 1.70K lbr · $156,281
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi